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Since 2011, consumer advocacy groups and plaintiffs have filed more than 150 food labeling class action lawsuits against food and beverage companies. According to a recent study, the number of these consumer protection class 
actions brought in federal court climbed from 19 cases in 2008 to more than 102 in 
2012.1 The majority of these cases have been filed in the U.S. District Court for the 
Northern District of California, now referred to as the “Food Court.” This surge in 
lawsuit filings has led some legal commentators to suggest that “food is replacing 
tobacco as the new regulatory and class action target.”2 This “unprecedented surge”3 
of deceptive labeling and advertising lawsuits against the makers of products such 
as Naked Juice, Fruit Roll-Ups, Bear Naked Granola, and Wesson Oil, reveals a trend 
of regulation by litigation—that is, a turning over of food labeling issues to the courts 
in light of a lax regulatory system. Although the Food and Drug Administration (FDA) 
is charged with regulating food labeling, plaintiffs’ attorneys are seeking to fill a void 
in the FDA’s regulatory authority and enforcement of food labeling laws. This paper 
provides an overview of the recent food labeling litigation and explores the reasons 
for this flood of litigation. However, this paper does not evaluate the merits of the 
lawsuits. Although none of these food labeling lawsuits have yet been adjudicated, 
the litigation has exposed problems with the FDA’s regulatory oversight of food label-
ing. The lawsuits represent attempts by consumer groups and plaintiffs’ attorneys to 
influence marketing behavior of food companies—a task more properly undertaken by 
the FDA.
Recognizing that consumers have the right to expect that the information on food 
labels is accurate and not misleading, the FDA has assured consumers, in a message 
on its website, that it “has your back.” To that end, “as resources permit,” FDA 
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monitors food products to ensure that the labels are truthful and not misleading. If a product 
is not properly labeled, the agency claims that it takes appropriate action. However, as this 
paper will demonstrate, the FDA lacks the resources and regulatory authority to effectively 
monitor false and misleading labeling practices. Such practices, which are the target of the 
food labeling lawsuits, have resulted in consumer confusion and an uneven playing field in the 
marketplace. In light of these issues facing consumers and food producers, this paper offers 
the following recommendations to address the issues highlighted by the recent 
labeling lawsuits: 
• The FDA should define misleading terms such as “natural” to achieve uniformity 
and consistency for consumers and food manufacturers. The issue of whether 
genetically modified ingredients are “natural” is at the core of many recent 
food labeling class-action suits. The agency should address the controversial 
genetically modified organism (GMO) labeling issue to prevent the state-by-state 
patchwork of laws that is beginning to develop. 
• The FDA should address the misleading nature of health and nutrition 
claims on foods and revise its regulations accordingly. Research conducted 
by the FDA and other groups proves that consumers are confused about 
these claims, particularly structure/function claims which do not require the 
FDA’s pre-approval or authorization. However, the FDA has not increased its 
enforcement efforts, nor has it provided clear guidance to manufacturers about 
the level of scientific support required to assert such claims. The “significant 
scientific agreement” standard should be required for each type of claim 
included on food labels. 
• The FDA should increase its monitoring and enforcement of labeling practices 
by coordinating efforts with the FTC, developing a comprehensive food labeling 
monitoring system, and instructing inspectors on how to identify potentially 
misleading claims. 
OVERVIEW OF THE FDA’S AUTHORITY
The Food and Drug Administration (FDA) is responsible for protecting the public health by 
ensuring the safety and proper labeling of all domestic and imported food except meat, 
poultry, and processed eggs, which are regulated by the U.S. Department of Agriculture’s 
(USDA) Food Safety and Inspection Service (FSIS). Eighty percent (80%) of the U.S. food 
supply, including fresh fruits and vegetables, dairy, baked products, and seafood, which 
equates to $417 billion worth of domestic food and $49 billion worth of imported foods,4 
is regulated by the FDA. In addition to protecting our nation’s food supply, the FDA is also 
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charged with overseeing human and veterinary drugs, vaccines, medical devices, cosmetics, 
dietary supplements, and tobacco products. The FDA’s Center for Food Safety and Applied 
Nutrition (CFSAN) is responsible for food and cosmetic products. Within CFSAN, the Office of 
Nutrition, Labeling, and Dietary Supplements publishes regulations and guidance regarding 
food labeling requirements. FDA’s Office of Regulatory Affairs (ORA), in cooperation with state 
agencies, conducts food safety inspections. Although food safety is the primary focus of an 
inspection of a food facility, inspectors are also directed to review the labels of at least three 
food products of any manufacturer or processor during every food safety inspection. The FDA 
also follows up on complaints from groups or individuals who believe that they have identified 
misbranded food. 
The Federal Food, Drug, and Cosmetic Act (“FDCA”) of 1938 grants the FDA the power 
to “promulgate food definitions and standards of food quality.”5 This power includes the 
regulation of nutritional labeling if a manufacturer makes nutritional or health claims about 
a food product, such as “low fat” or “high in fiber.” In response to growing concern about 
inconsistent and unclear terms on food labels used to describe nutrient content, Congress 
enacted the Nutrition and Labeling Education Act (NLEA)6 in 1990, which amended the FDCA 
for nearly all food products within the FDA’s jurisdiction to regulate health claims on food 
packaging, standardize nutrient content claims, and require that more detailed nutritional 
information be included on product labels.7 
The FTC and the FDA have overlapping jurisdiction to regulate the advertising and labeling of 
foods.  Section 403(a) of the FDCA prohibits the “misbranding” of food which includes labeling 
that “is false or misleading in any particular.”8 Section 5 of the Federal Trade Commission 
Act (FTC Act) prohibits “unfair or deceptive acts or practices,” and Sections 12 and 15 of the 
FTC Act prohibit “any false advertisement” of food products that is “misleading in a material 
respect.”9 This shared jurisdiction over labeling and advertising of food products operates 
pursuant to a longstanding Memorandum of Understanding between the agencies.10 Under this 
agreement, the FDA exercises primary responsibility for regulating food labeling, while the FTC 
assumes primary responsibility for ensuring that advertising of food products is truthful and 
not misleading. 
Although the FDA is responsible for enforcing labeling regulations, it lacks the enforcement 
authority to effectively deter food companies from making misleading claims. When the FDA 
determines that a manufacturer has violated a labeling regulation, the agency’s principal 
enforcement tool is to issue a Warning Letter to notify the manufacturer. These Letters are 
issued to achieve voluntary compliance and to establish prior notice.  In general, the FDA may 
exercise enforcement strategies such as recall, seizure, injunction, administrative detention, 
civil money penalties or criminal prosecution.11 However, these other measures are reserved 
for violations other than the misbranding violations at issue in the recent food labeling 
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lawsuits. The FDA may enforce compliance with a recall order or impose civil monetary fines 
when adulteration or misbranding of food “will cause serious adverse health consequences of 
death,”12 such as when a label is missing allergen information.13 The FDA may condemn and 
seize misbranded foods only after the company receives proper notice and the opportunity 
to respond and the FDA has “probable cause to believe . . . that the misbranded article is 
dangerous to health, or that the labeling of the misbranded article is fraudulent, or would 
be in a material respect misleading to the injury or damage of the purchaser or consumer.”14 
Injunctions or criminal prosecutions are rarely used for food misbranding because the 
FDCA expressly provides that these enforcement actions should not be initiated for “minor 
violations” when the “public interest” may be adequately served by a written warning.15 Thus, 
the FDA primarily seeks voluntary compliance from food companies when food products are 
misleading or mislabeled. As the food labeling lawsuits demonstrate, these Warning Letters 
provide little incentive or threat for companies to avoid or discontinue use of misleading claims 
on food labels. 
The FDA’s Regulation of Health and Nutrition Claims
Pursuant to its statutory authority under NLEA, the FDA promulgated regulations regarding 
permissible nutrient content and health claims on food labels. FDA regulations permit three 
categories of health and nutrition claims on food packaging: health and qualified health 
claims, nutrient content claims, and structure/function claims. Each type of claim is subject to 
different rules.  
A health claim expressly or implicitly, through the use of statements, symbols, or vignettes, 
“characterizes the relationship of any substance to a disease or health-related condition.”16 
Health claims must be reviewed and evaluated by the FDA prior to use.17 Health claims are 
limited to claims about disease risk reduction, and cannot be claims about the diagnosis, cure, 
mitigation, or treatment of disease. The FDA authorizes unqualified health claims on product 
labels only if the substance/disease relationship described by the health claim is supported by 
“significant scientific agreement, among experts qualified by scientific training and experience 
to evaluate such claims.” This is referred to as the Significant Scientific Agreement (SSA) 
standard.18  To use an SSA claim, the product must meet detailed regulatory requirements and 
must not exceed disqualifying levels of total fat, saturated fat, cholesterol and sodium19 or, if 
prior to fortification, the food does not contain at least ten percent (10%) of the Reference 
Daily Intake of Vitamin A, Vitamin C, iron, calcium, protein, or fiber.20 This minimum nutrient 
requirement, known as the “Jelly Bean” rule, prohibits health claims for soft drinks, chewing 
gums, bottled waters, and other foods and beverages. The nutrient, such as fiber, that is the 
subject of the health claim must be present at levels that are at least twenty percent (20%) of 
the Daily Value (DV) or in amounts specified by FDA.21 Finally, approved health claims require 
that claims be phrased in a particular way, indicating that the disease at issue may be caused 
by a variety of factors, and that the product must be consumed as part of a healthy diet. For 
Food Labeling Litigation        5
example, a permissible health claim on an oatmeal label would state that: “three grams of 
soluble fiber from oatmeal daily in a diet low in saturated fat and cholesterol may reduce the 
risk of heart disease. This cereal has 2 grams per serving.” 
Prior to 2002, the FDA rejected health claims that did not meet the SSA standard. However, 
in response to litigation that raised First Amendment challenges to this standard, the 
FDA has permitted qualified health claims on foods. When the evidence for a substance/
disease relationship is credible but does not meet the SSA standard, FDA issues a Letter of 
Enforcement Discretion to the food manufacturer petitioning for use of the health claim. This 
Letter indicates that the FDA would not object to the use of the health claim, provided that 
the claim is “qualified” by a disclaimer or other language expressly stated in the Letter to 
characterize the strengths and limitations of the claim’s scientific support. Such qualification is 
intended to address the claim’s potentially misleading nature. An example of a qualified health 
claim for green tea states, “Two studies do not show that drinking green tea reduces the risk of 
breast cancer in women, but one weaker, more limited study suggests that drinking green tea 
may reduce this risk. Based on these studies, FDA concludes that it is highly unlikely that green 
tea reduces the risk of breast cancer.” Because of the awkward wording of qualified health 
claims, many food manufacturers disfavor their use. 
A nutrient content claim, which is the claim most frequently used on food products, directly or 
implicitly characterizes the level of a nutrient in the food, using terms such as, “low,” “high,” 
“free,” “reduced” or “light.”22 The FDA has established specific standards and definitions 
for each nutrient content claim that may be used, such as “low fat” or “high in fiber.” Even 
the ubiquitous term “healthy” has a very specific meaning for use on food labels under the 
FDA’s regulations. The term “healthy” may be used only if a food is low in fat, contains limited 
amounts of cholesterol, and if it is a single-item food, it provides at least ten percent (10%) of 
the DV per serving of at least one of these: vitamins A or C, iron, calcium, protein and fiber.23
Unlike the strictly defined and regulated health and nutrient content claims, the FDA does not 
authorize or pre-approve structure/function claims, nor has it indicated the level of scientific 
support needed to prevent false or misleading information for such a claim.24 Structure/
function claims describe the effect that a substance has on the structure or function of the 
body, but they do not make reference to a disease. An example of such a claim is: “calcium 
builds strong bones.” The FDA does not require food manufacturers to substantiate 
structure/function claims, nor does the FDA mandate the use of disclaimers when theses 
claims are used. 
THE RISE IN CLAIMS MADE ON FOOD LABELS: 
SHIFTING CONSUMER PREFERENCES 
As the American obesity “epidemic”25 has become one of the most pressing public health 
issues, consumers have been increasingly demanding healthier food products. While the 
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Center for Disease Control (CDC) reports that more than one-third of U.S. adults (35.7%) are 
obese,26 a 2013 Healthy Eating Consumer Trend Report shows that sixty-four percent (64%) 
of consumers (an increase from fifty-seven percent (57%) in 2010) agree on the importance 
of healthy eating and nutrition.27  Consumer demand for healthier food has led to an increase 
in organic food sales from approximately $11 billion in 2004 to an estimated $27 billion in 
2012.28 Over the past decade, consumer demand for locally produced foods has also grown 
dramatically. A USDA Rural Development Service Report refers to the availability and demand 
for locally produced products as “unprecedented in recent history.” Consumer demand for 
these products has led to the growth of local farmers’ markets and Community Supported 
Agriculture (CSAs).29 In the past decade, the number of farmers’ markets has increased from 
1,755 in 1994 to 8,144 in 2013. Between 2012 and 2013, there was a 3.6 percent increase.30 
In light of this new focus on local, fresh, and healthy food, processed food manufacturers have 
introduced onto supermarket shelves hundreds of processed foods claiming, to be “natural,” 
“wholesome,” “simple” or “pure.” These efforts to create more apparently healthful processed 
foods have paid off. For example, in the United States, consumers have spent more than 
$40 billion on food labeled “natural” over the past year, and 51% of Americans search for 
“all natural” products when shopping.31 Foods labeled as “natural” accounted for about ten 
percent (10%) of all grocery sales in 2013, while organic food and products made up about five 
percent (5%) of all grocery sales that year, according to a report by the Organic Consumers 
Association.32 A 2013 study by the USDA’s Economic Research Service found that from 2001 to 
2010, health and nutrition claims became an increasingly important feature of labeling on new 
products. For example in 2009, sales of products with claims related to fat, sodium, 
and calories accounted for $73 billion in sales or twelve percent (12%) of food sales for 
at-home consumption.33 
The “American obesity paradox”—the simultaneous increase in obesity rate and demand for 
healthful foods-- may be explained by the so-called “health-halo” claims made on foods.34 The 
theory is that people tend to overestimate the healthfulness of a food based on one perceived 
attribute of the food, such as “organic,” “natural,” or containing “whole grains.” With claims 
such as “natural” on processed foods, consumers feel better about eating these convenience 
foods even though they may in fact be anything but “natural.” Judging a food as more 
healthful, may lead people to eat more of that food. This is certainly a positive phenomenon 
for food producers, but one has had a deleterious effect on consumers’ waistlines. Feeding 
consumers’ demand for “natural,” “pure,” and “healthful” products has led to the widespread 
use of these claims, many of which are confusing or misleading, on a wide variety of products. 
As FDA Commissioner Hamburg noted in 2010, “[W]ith consumers’ growing interest in eating 
healthy, we’ve seen the emergence of eye-catching claims and symbols on the front of food 
packages that may not provide the full picture of their products’ true nutritional value.”35 
Although the FDA has established regulations for permissible health and nutrition claims, it 
Food Labeling Litigation        7
has been unable to keep pace with the influx of new products labeled with novel, unregulated, 
and allegedly misleading claims. 
It is against this backdrop of increased consumer demand for healthy foods, a surge in the 
number of health, nutrition, and other claims, such as “natural,” on food products, and 
limited oversight by the FDA, that consumer advocacy groups turned to the courts to address 
deceptive food labeling practices. 
A BRIEF HISTORY OF FOOD LABELING LITIGATION
As claims on food labels were used more frequently, the FDA’s oversight of claims was 
declining.36 In 2004, the nonprofit consumer advocacy group Center for Science in the 
Public Interest (CSPI) established its litigation department “to fill the void left by the 
inactive government agencies by using state and federal courts to help correct corporate 
misbehavior.”37 In light of the government’s inaction, CSPI’s policing efforts uncovered 
hundreds of food labeling violations. During the next several years, CSPI achieved several 
significant victories by suing or threatening to sue food and beverage manufacturers for 
allegedly deceptive labeling practices. For example, in 2005, CSPI reached a settlement 
after threatening to sue Aunt Jemima’s corporate parent, Pinnacle Foods, for the misleading 
labeling of “blueberry” waffles that contained no actual blueberries. The “artificially flavored 
blueberry bits” in the waffles were made from ingredients such as sugar, dextrose, partially 
hydrogenated soybean oil, soy protein concentrate, and food dyes such as Blue 2 Lake and 
Red 40 Lake. Pinnacle Foods agreed to more clearly indicate that the product is “artificially 
flavored” and that the “blueberries” are imitation. 
CSPI achieved similar success when it convinced General Mills to indicate on its package that 
its Super Moist Carrot Cake Mix contains only carrot-flavored bits, Quaker Oats to revise 
labels to inform consumers that several of its instant oatmeal and grits did not contain any 
real fruit, real butter, or real meats, as the labels implied, and Sara Lee agreed to change its 
labels to clarify that its “Soft & Smooth Made With Whole Grain White Bread” contains only 
thirty percent (30%) whole grains rather than claiming the product is nutritionally equivalent 
to one hundred percent (100%) whole wheat bread. After suing Kraft for deceptive labeling 
of Capri Sun drinks as “natural,” although they were sweetened with high-fructose corn syrup 
(HFCS), Kraft agreed to discontinue use of the claim. Similarly, CSPI’s threat of litigation halted 
Cadbury-Schweppes’ labeling of 7UP containing high-fructose corn syrup as “All Natural.”
By 2005, Congress was so concerned by the prevalence of labeling violations that it asked the 
FDA to report on the types of food labeling violations, other than those relating to safety, that 
the agency had uncovered and the actions taken to address them. The Senate Appropriations 
Committee wanted to prevent misleading claims and ensure that “food labels can be easily 
understood and reflect information that is factual” and not misleading.38 The House of 
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Representatives was concerned about the loss of consumer confidence in food labels because 
of misleading claims such as “healthy” and inaccuracies in the amount of nutrients stated in 
the Nutrition Facts Panel.39  
In October 2008, the GAO criticized the FDA for failing to keep pace with the growing number 
of food companies and producers. Although the number of food producers had grown 
significantly, the number of inspections, Warning Letters, and enforcement actions to address 
labeling violations decreased or had remained steady.40 As CSPI noted, “[g]iven the number of 
violations identified by CSPI, state officials, aggrieved competitors and consumers, the small 
number of Warning Letters issued by the Agency is an indication that the FDA has all but 
abdicated its responsibility to police inaccurate nutrition statements and misleading health-
related claims on food labels.”41 The GAO cited specific failures such as the lack of reliable 
data on the number of labels that were actually reviewed during facility inspections, decline in 
number of inspections and label reviews, and failure to track labeling violations or ensure that 
complete information about problems is promptly posted to the Web to inform the public.42 
Therefore, the GAO concluded that “FDA has limited assurance that domestic and imported 
foods comply with food labeling requirements, such as those prohibiting false or 
misleading labeling.”43
In light of flagrant labeling violations abounding in the marketplace and pressure from CSPI 
and Congress, in 2009 the FDA announced that reliable nutrition labeling of food products was 
a top priority for the agency. In October 2009, the FDA issued a “Dear Industry” letter, noting 
its concern with the number and variety of potentially false or misleading claims, including 
nutrient content claims not expressly permitted by the FDA.44 In this letter, the FDA urged 
food manufacturers to examine their product labels and comply with the FDCA. The letter, 
which was merely a “nonbinding recommendation,” did not have much impact on the industry. 
CSPI’s 2010 Food Labeling Chaos Report identified a variety of food labeling problems creating 
consumer confusion and criticized several companies for violations that were unnoticed by 
the FDA. As CSPI noted in its Report, although the FDA was beginning to address labeling 
violations, it was “merely scraping the tip of the iceberg.”45 Following the Report’s publication 
in January 2010, two months later in March, FDA Commissioner Margaret Hamburg issued an 
open letter to the food industry, again urging all manufacturers to review their labels for FDA 
compliance and reiterating the agency’s commitment to ensuring the truthfulness of food 
labels.46 As part of a food labeling enforcement initiative, the FDA issued 17 Warning Letters 
on a single day to food manufacturers for FDCA violations such as making unauthorized health 
claims and nutrient content claims, failing to meet the well-established standard for foods 
labeled as “healthy,” and making unauthorized claims on products for infants and children 
less than two years of age. Despite this showing of authority, misleading labels continued to 
proliferate in the marketplace. 
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In July 2010, Michael R. Taylor, the FDA’s deputy commissioner for foods, identified some 
challenges facing the FDA in its oversight of food labeling violations: 
We will no doubt issue more letters on labeling violations, but I do not see us 
eradicating questionable claims . . . through a letter writing campaign or other means 
any time soon. We have no pre-market review authority over such claims, and, under 
prevailing legal doctrines concerning “commercial free speech,” the evidentiary 
requirements placed on FDA to prove that such claims are misleading are significant 
and costly to meet. Moreover, meeting them requires tapping the same team of 
nutritionists, labeling experts, and lawyers who are working on our other nutrition 
initiatives.
We’re also conscious of the cleverness of marketing folks, who, once we prove today’s 
claim is misleading, can readily come up with another one tomorrow. Going after 
them one-by-one with the legal and resource restraints we work under is a little like 
playing Whac-a-Mole, with one hand tied behind your back.47
These statements admitting the FDA’s defeat in a battle for truthful food labeling, 
was discouraging for consumers and honest food manufacturers, but promising for 
plaintiffs’ attorneys.
In the absence of FDA’s oversight, consumer and public health groups have been policing the 
marketplace for misleading and deceptive labeling practices. The settlements CSPI achieved 
with several large food manufacturers proved that lawsuits could be successful in changing 
corporate behavior. Plaintiffs’ lawyers, many of whom had litigated the tobacco cases,48 
recognized an area of the law ripe for litigation. The Dannon $45 million settlement in 2010 
demonstrated that the lawsuits could also prove lucrative. Dannon’s settlement of a class 
action alleging it made false claims about the digestive benefits of Activia probiotic yogurt 
was arguably the first major victory against a food company.49 Therefore, this case may have 
sparked the first wave of food labeling lawsuits alleging misleading health claims. Plaintiffs 
have also achieved more recent successes— in 2013 plaintiffs won a $9 million settlement with 
PepsiCo over claims that Naked Juice products were deceptively advertised and labeled as 
“all natural” and “non-GMO” when its products actually contained processed and synthetic 
ingredients and ingredients from genetically modified crops.50 General Mills agreed to pay 
plaintiffs $8.5 million to settle claims that Yoplait Yo-Plus made false claims about its yogurt 
having digestive health benefits.51 Kellogg’s settled a lawsuit for $4 million in which plaintiffs 
claimed that it falsely advertised that its Frosted Mini-Wheats cereal as improving kids’ 
attentiveness, memory and other cognitive functions to a degree not supported by competent 
clinical evidence52 and cereal maker Barbara’s Bakery also paid $4 million to settle claims 
that the company mislabeled its cereal and snack products as “all natural” when they actually 
contain genetically modified ingredients.53
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Enforcement actions by the FDA and FTC also inspired consumer class action lawsuits alleging 
violations of state consumer protection laws. For example, on May 5, 2009, the FDA issued 
a Warning Letter to General Mills for making unauthorized health claims on Cheerios. In its 
letter, the FDA explained that Cheerios’ claims such as “you can Lower Your Cholesterol 4% 
in 6 weeks” indicate that Cheerios is intended for use in lowering cholesterol, and therefore 
in “preventing, mitigating, and treating” hypercholesterolemia and coronary heart disease. 
Because of this intended use, under the FDCA Cheerios would be considered a drug which 
may not be legally marketed without undergoing a formal drug approval process.54 Soon after 
the Warning Letter was issued, several class action lawsuits, later consolidated into one multi-
district suit at the New Jersey District Court, were filed. The lawsuits, which were ultimately 
dismissed, alleged that General Mills made false claims which induced the plaintiffs to purchase 
the cereal as a way to lower cholesterol.55 Another example of a piggybacking class action was 
brought against Alexia Foods after the FDA issued a Warning Letter in 2011 to Alexia Foods 
regarding its improper use of a “natural” claim. The FDA indicated that the “natural” claim 
on Alexia’s Roasted Red Potatoes & Baby Portabella Mushrooms was false and misleading 
and therefore constituted misbranding because the product contained disodium dihydrogen 
pyrophosphate, a synthetic chemical preservative.56 In May 2012, a class action lawsuit alleging 
that a variety of Alexia’s frozen potato products were falsely labeled as “all-natural” piggy-
backed on this Warning Letter.57 The case was settled for $3.2 million in July 2013.58
OVERVIEW OF LABELING LAWSUITS
The lawsuits against food and beverage companies generally fall into two categories: claims 
that are legal or unregulated, but are nevertheless allegedly misleading, and claims that 
violate state laws equivalent to the FDCA and the FDA’s regulations. Most of the recent 
lawsuits involve claims such as “all natural,” “nutritious,” or “healthful” that are permitted or 
not regulated by the FDA, but are nonetheless misleading. Lawsuits challenging these types 
of claims have frequently involved a variety of products such as cookies, granola, smoothie 
kits, canned tomatoes, ice cream, and cooking spray, containing ingredients like high fructose 
corn syrup, alkalized cocoa, ascorbic acid, and GMOs. Other recent lawsuits involve alleged 
misbranding violations that are covered by FDA regulations and policies, and the equivalent 
state law, such as health and “nutrient content” claims. Other lawsuits reveal food fraud 
occurring in the market. For example, in one lawsuit plaintiffs claim that a “grape seed oil” 
product is falsely labeled because it allegedly contains less than 25% grape seed oil.59 Another 
similar lawsuit alleges that defendant’s olive oil is falsely labelled “100% Pure Olive Oil,” 
because it actually contains “olive-pomace oil,” “olive-residue oil,” or “pomace.”60  
Neither the FDCA nor the FTC Act provides for a private right of action.61 In other words, 
although the FDA and FTC may enforce the requirements of their respective statutes and 
regulations, private litigants cannot bring a private cause of action or class action against 
a company that relies solely on a violation of the FDCA or the FTC Act. Although the NLEA 
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includes an express preemption requirement which prohibits a state from establishing food 
laws that are not identical to the requirements of the FDCA,62 states may permit causes of 
action based on violations of state laws that mirror the federal requirements. California’s 
Sherman Law, for example, expressly adopts the federal labeling requirements of the FDCA 
and NLEA, such as the prohibition of “false or misleading” labeling.63 
Therefore, the food labeling lawsuits have been predicated upon violations of state statutes on 
false advertising, unfair trade practices, consumer protection, fraud, and breach of warranty.64 
Most of the food labeling lawsuits filed in California allege violations of the Unfair Competition 
Law (“UCL”)65 predicated on violations of the False Advertising Law (“FAL”)66 or the Consumer 
Legal Remedies Act (“CLRA”).67 The UCL, FAL, and CLRA are California consumer protection 
statutes which prohibit deceptive practices and misleading advertising.68 Violations of the 
Sherman Law are unlawful business practices under §17200 of the UCL. These lawsuits are 
generally based upon the allegation that certain information on the packaging of the food 
products was false or misleading and that consumers reasonably relied on that information to 
their detriment.69 
A. “Natural” Litigation 
 The majority of food labeling lawsuits, at least 100 filed since 2011,70 have alleged the 
misleading use of the “natural” claim. Confusion and ambiguity regarding the term’s meaning 
can largely be attributed to the FDA’s reluctance to establish an enforceable standard for 
the claim.
 
 1. The FDA’s Natural Policy 
 Although the FDA has seemed to recognize the importance of formally defining this term and 
has recognized that an adequate definition could prevent consumer confusion,71 the agency 
nevertheless has declined to adopt a formal definition. In 1991, it adopted an “informal policy,” 
which states that “natural” means merely that “nothing artificial or synthetic (including colors 
regardless of source) is included in, or has been added to, the product that would not normally 
be expected to be there.”72 The policy carries only the weight of an advisory opinion, and it 
does not establish a legal requirement.73
In 1993, when it initiated rulemaking to implement the NLEA, the FDA invited comments on a 
potential rule regarding the definition of “natural.”74 After receiving a variety of suggestions, 
from banning use of the term, to allowing free use of the term, the FDA recognized that “use 
of the term ‘natural’ on [a] food label is of considerable interest to consumers and industry. . . 
.”75 However, it concluded that “[n]one of the comments provided FDA with a specific direction 
to follow for developing a definition” for the use of the word “natural.”76
After reviewing and considering the comments, the agency continues to believe that 
if the term “natural” is adequately defined, the ambiguity surrounding use of this 
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term that results in misleading claims could be abated. However, as the comments 
reflect, there are many facets to this issue that the agency will have to carefully 
consider if it undertakes a rulemaking to define the term “natural.”77 
The FDA concluded, “[b]ecause of resource limitations and other agency priorities, FDA is 
not undertaking rulemaking to establish a definition for ‘natural’ at this time.”78 Instead, the 
FDA has maintained its informal policy and has announced that its determination of whether 
an ingredient would qualify for use of the term “natural” on a case-by-case basis, rather than 
adopting a consistent, uniform policy.
 On its Web site, the FDA has provided consumers the following explanation of the meaning of 
“natural” food labels:
From a food science perspective, it is difficult to define a food product that is 
“natural” because the food has probably been processed and is no longer the product 
of the earth. That said, the FDA has not developed a definition for use of the term 
natural or its derivatives. However, the agency has not objected to the use of the term 
if the food does not contain added color, artificial flavors, or synthetic substances.79
Because the FDA has refused to provide a definitive and enforceable standard for use of the 
term “natural,” the issue of what constitutes a “natural” ingredient is now before judges in the 
dozens of lawsuits alleging deceptive use of the term. However, the FDA’s repeated reluctance 
to establish a definition or enforceable standard for the term was recently challenged by 
several judges who decided that the FDA, not the courts, should decide this issue. The order 
in Cox v. Gruma Corporation, referred the issue of GMOs and labeling of “natural” foods to 
the FDA for the first time.80 In providing the FDA with an opportunity to address the question, 
the court recognized that “[t]he FDA has regulatory authority over food labeling,” the FDCA 
“establishes a uniform federal scheme of food regulation to ensure that food is labeled in a 
manner that does not mislead consumers,” and food labeling “requires the FDA’s expertise and 
uniformity in administration.”81 
The court agreed with the plaintiff’s position that there is “a gaping hole in the current 
regulatory landscape for ‘natural’ claims and GMOs.”82 Although the FDA has not addressed 
the question of whether foods containing GMO or bioengineered ingredients may be labeled 
“natural,” or whether those ingredients would be considered “artificial or synthetic,” the court 
concluded that the FDA is charged with resolving the issue. It thus referred to the FDA “the 
question of whether and under what circumstances food products containing ingredients 
produced using bioengineered seed may or may not be labeled ‘Natural’ or ‘All Natural’ 
or ‘100% Natural.’ ”83 Otherwise, the court reasoned, it “would risk ‘usurp[ing] the FDA’s 
interpretive authority[,]’ and ‘undermining, through private litigation, the FDA’s 
considered judgments.’ ”84  
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On January 6, 2014, the FDA responded to the court and declined the opportunity to address 
the issue.85 In a letter from Leslie Kux, the FDA’s Assistant Commissioner for Policy, the FDA 
cited several reasons for its refusal to define “natural.”86 First, it noted that amending its 
“natural” policy would likely involve “a public process, such as issuing a regulation or formal 
guidance,” rather than an ad hoc decision made “in the context of litigation between private 
parties.”87 Acknowledging the complexity of the issue and the competing interests of various 
stakeholders, Ms. Kux stated that “it would be prudent and consistent with FDA’s commitment 
to the principles of openness and transparency to engage the public on this issue.”88 The 
letter also noted that defining “natural” would require coordination and cooperation with the 
USDA and other agencies.89 Reconsidering its “natural” policy would entail a consideration 
of scientific evidence, consumer preferences and beliefs, food production and processing 
methods, and First Amendment issues.90 Finally, the FDA again noted its lack of resources and 
identified other priorities, such as regulations implementing the Food Safety Modernization 
Act of 2011 and nutrition labeling regulations.91
Although the FDA has refused to formally define the term “natural,” it has sent a number of 
Warning Letters to companies who have violated the informal policy.92 For example, on April 
3, 2012, the FDA issued an import alert against an Israeli “berry juice,” citing, among other 
things, its claim of “natural” despite the inclusion of sulfur dioxide. In the letter, the FDA 
explained that although it “has not established a regulatory definition for the term natural[,] 
. . . the Agency has a long-standing policy that restricts the use of the term natural when a 
product is formulated with added color, synthetic substances, and flavors . . . that would not 
normally be expected to be in the food.” Because the product contains “sulfur dioxide, which is 
listed in the ingredient statement as a preservative, . . . the product name can not [sic] include 
the term Natural.”93 As the following discussion of the “natural” lawsuits demonstrates, these 
Warning Letters have had little effect on curbing misleading use of “natural” claims.
2. “Natural” Lawsuits
The “natural” lawsuits generally target four categories of products: products containing 
artificial preservatives, products processed with chemicals or containing other unnatural 
ingredients, products containing HFCS, and products containing genetically modified 
organisms (GMOs).
Examples of lawsuits filed against companies whose products are labeled “natural” but contain 
artificial ingredients and preservatives include: 
• Consolidated complaints against Kashi and Kellogg’s alleged that these 
companies cultivated a wholesome and healthful image by promoting their 
products as “all natural” or containing “nothing artificial,” when the products 
contained substances like ascorbic acid, calcium pantothenate, calcium 
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phosphates, potassium carbonate, pyridoxine hydrochloride, sodium acid 
pyrophosphate, sodium phosphates, tocopherols, and/or xanthum gum.94  
• Class-action lawsuits have been filed against Ben & Jerry’s Homemade, Inc., 
on behalf of consumers who purchased Ben & Jerry’s “all natural” ice cream 
products containing alkalized cocoa.95 According to the Complaint, alkalized 
cocoa is “a non-natural processed ingredient” containing “potassium carbonate, 
a man made, synthetic ingredient.” 
• A lawsuit against Bear Naked, Inc., alleged that the company’s products labeled 
“100% Pure & Natural” actually contain synthetic ingredients such as potassium 
carbonate, glycerin, and lecithin.96  
• South Beach Beverage Co. and PepsiCo, were sued by plaintiffs alleging that 
the companies market their SoBe beverages as “all natural” when they do not 
contain juice from any of the fruits described in their names and  
contain substances created by chemical processing, including ascorbic  
acid, cyanocobalamin, calcium pantothenate, niacinamide, and  
pyridoxine hydrochloride.97  
• Most recently, Whole Foods Market was accused of falsely advertising baked 
goods such as banana muffins, chocolate chip cookies and apple pie as being 
“all natural,” even though they contain synthetic chemical ingredients  
such as sodium acid pyrophosphate and other synthetic ingredients such  
as maltodextrin.98  
Since 2007, class actions have been filed against the makers of AriZona beverages,99 Snapple 
Beverage Corp.,100 ConAgra Healthy Choice pasta sauces,101 and General Mills Nature Valley 
products102 for advertising their products as “100% Natural” when they contained HFCS.  
The Complaints allege that HFCS is “a highly processed sugar substitute that does not exist 
in nature.”103 
The most recent wave of lawsuits has been filed against companies whose products contain 
GMOs and are advertised as “all natural.” Although the FDA does not recognize any meaningful 
difference between GMOs and foods developed by traditional plant breeding and therefore 
does not require labeling of GMOs,104 these lawsuits allege that GMOs are inherently unnatural. 
To support this allegation, several of the lawsuits cite to Monsanto’s own definition of GMOs, 
as “[p]lants or animals that have had their genetic makeup altered to exhibit traits that are not 
naturally theirs. In general, genes are taken (copied) from one organism that shows a desired 
trait and transferred into the genetic code of another organism.”105 Examples of  
lawsuits include:
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• Class-action lawsuits have been filed against General Mills, alleging the company 
engaged in a widespread marketing campaign to mislead consumers about the 
nature of the ingredients in its Kix cereals.106 The lawsuit alleges that General 
Mills is able to command a premium for its cereals by deceiving customers into 
believing they are made with “All Natural Corn,” when the corn used in the 
cereals is actually derived from genetically modified plants.  
• Lawsuits against Frito-Lay and PepsiCo claim that the companies’ Tostitos and 
SunChips products were not “made with all natural ingredients” because the 
corn and oils used to make them were made from genetically modified plants.107  
• ConAgra Foods was sued for including genetically modified corn and soy in the 
Wesson line of cooking oils which are labeled as “all-natural.”108  
• A lawsuit against Pepperidge Farm, Inc., alleged that the company misleads 
consumers by labeling its Cheddar Goldfish crackers “natural,” because they 
contain GMOs.109  
B. Misleading Claims Not Regulated by the FDA 
Similar to the “natural” claims cases, plaintiffs have also filed lawsuits alleging misleading use 
of a variety of claims that are permitted, but not regulated by the FDA, such as “nutritious” 
and “wholesome.” For example: 
• Plaintiffs alleged that Unilever falsely marketed its I Can’t Believe It’s Not Butter, 
Shedd’s Spread Country Crock, Brummel & Brown, and Imperial margarines 
as “nutritious,” “cholesterol free,” and “natural,” despite containing artificial 
trans fat.110 Plaintiffs also argued that Unilever made implied health claims by 
including the name of the popular health and nutrition website WebMD on the 
product’s label, suggesting that the product is nutritious and recommended by 
“MDs” when in fact there is a strong medical consensus against consuming any 
product containing artificial trans fat.  
• Plaintiffs alleged that Kraft falsely markets Ritz Crackers, Original Premium 
Saltine Crackers, Ginger Snaps, and Teddy Grahams as healthful and 
“wholesome” despite containing trans fat, which is “highly toxic to  
human health.”111 
• In a lawsuit against Nutella, which settled in January 2012 for $3 million,112 
plaintiffs alleged that consumers were misled by the claim that the spread is “an 
example of a tasty yet balanced breakfast.” This claim was allegedly deceptive 
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because it omits that the “balanced breakfast” is derived from the other foods 
or drinks which are depicted on the label, and Nutella contains high levels of 
saturated fat and over fifty-five percent (55%) processed sugar.113 
• In a lawsuit against Quaker Oats, plaintiffs argued that claims such 
“wholesome,” “help your family fuel their busy days,” “quality,” “goodness in 
every bowl,” “will help you feel your best,” “All the Nutrition of a Bowl of Instant 
Oatmeal!,” and “Helps Reduce Cholesterol,” on labels of   Quaker Oats’ Go Bars, 
Instant Quaker Oatmeal, and Quaker Chewy Bars are misleading because they 
include the unhealthy ingredient, partially hydrogenated oils (“PHOs”). In a 
recent settlement, although it disclaims any wrongdoing, Quaker agreed to 
remove PHOs from its products by the end of 2015 and will thereafter label any 
products containing trace amounts of PHOs as containing “dietarily insignificant 
amount of trans fat.” 114  
• Plaintiffs alleged that Tropicana falsely claimed that its “not-from-concentrate” 
orange juice is “100% pure” and “natural” orange juice; however, the product is 
“pasteurized, deaerated, stripped of flavor and aroma, stored for long periods  
of time before available to the public, and colored and flavored before  
being packaged.” 115   
• Plaintiffs brought suit against Hain Celestial Group Inc. alleging that the 
defendant’s “Unpasteurized,” “100% Raw,” and “Raw and Organic” labels on its 
BluePrint Juice and BluePrint Cleanse drinks mislead consumers because the 
high-pressure processing (HPP) with which the products are treated destroys 
“vital” enzymes and nutrients thus breaching “the fundamental principles 
underlying the raw food movement, consumers’ expectations and industry 
standards.”116 The FDA has not provided guidance regarding the labeling of an 
HPP-treated product.  
• More than 50 lawsuits have been filed since 2012117 against food producers 
such as Chobani,118 Lifeway Foods,119 and Blue Diamond,120 and Trader Joe’s121 for 
failing to list “sugar” or “dried cane syrup” in the ingredient section, but instead, 
referring to the ingredient as “evaporated cane juice” (ECJ) claims. Plaintiffs 
assert that these products are misbranded because the term is misleading and 
in violation of the FDA’s standard of identity regulations. 
In 2009, the FDA issued “Draft Guidance” and sent Warning Letters advising companies that 
the agency considers the term ECJ to be false and misleading under the FDCA because it fails 
to reveal the basic nature of the food and its properties (i.e., that the ingredients are sugars 
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or syrups). The Draft ECJ Guidance, which contains nonbinding recommendations and do not 
establish legally enforceable responsibilities, also states that because “juice” is defined as 
liquid coming from a fruit or vegetable, and sugar cane is not considered a “vegetable” in the 
sense that a consumer considers eating vegetables as part of her diet, the term “evaporated 
cane juice” should not be considered “juice” as that term is defined in the regulations. Despite 
the Warning Letters and Guidance, the term is frequently used on a variety of products. 
Because the FDA did not reach a final decision on the common or usual name for this 
ingredient, the FDA announced on March 5, 2014 that it is reopening the comment period to 
request further comments, data, and information about the basic nature and characterizing 
properties of the ingredient sometimes declared as “evaporated cane juice,” how this 
ingredient is produced, and how it compares with other sweeteners.122 
C. Unsubstantiated Health and Nutrition Claims 
Although the FDA’s regulations require pre-approval of health claims made on foods and 
beverages, alleged violations of these regulations has provided fodder for food labeling 
litigation. One type of frequently alleged claim concerns misleading statements about the 
health benefits of the product.  
• For example, CSPI sued Coca-Cola and Nestlé in 2007 for making fraudulent 
claims in marketing and labeling Enviga, an artificially sweetened green tea 
soft drink. Labeled “the calorie burner” on cans, Enviga was marketed as a 
weight-loss aid, with claims that it had “negative calories” and that it could 
“keep those extra calories from building up.”  CSPI alleged that claims were 
made without prior substantiation and no evidence that most consumers 
would realize any calorie-burning benefit.123 Following the filing of this lawsuit, 
approximately 28 state attorneys general investigated the claims and ultimately 
settled for $650,000. Coca-Cola and Nestlé also agreed to add disclosures 
to Enviga, and any similarly formulated product, to disclaim any weight loss 
benefits and note that weight loss is only possible through diet and exercise. 
 
• CSPI served as co-counsel to sue Coca-Cola over allegedly deceptive and 
unsubstantiated claims on its Vitaminwater line of beverages, which are 
labeled with words evoking health, such as “defense,” “rescue,” “energy,” and 
“endurance.” The beverages also claim to reduce the risk of chronic disease, 
reduce the risk of eye disease, promote healthy joints, and support optimal 
immune function. CSPI alleges that these claims are deceptive because the 
drinks contain a substantial amount of sugar and despite the full names of 
the drinks, such as “endurance peach mango” and “focus kiwi strawberry,” 
Vitaminwater contains between zero and one percent juice.124
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• Plaintiffs alleged false docosahexaenoic acid (DHA) brain health claims for Dean 
Foods’ Horizon Organic Milk. Plaintiffs argued that DHA-fortified milk products 
do not support brain health in children or adults and Dean Foods also does 
not have competent and reliable scientific evidence to support its brain health 
representation. Although the company modified its radio, television, print and 
online advertisements following an FTC investigation of the “DHA Omega-3 
Supports Brain Health” claim, Dean Foods has not changed product labels  
and packaging.125 
• CSPI has recently sent a demand letter to Smart Balance, Inc., identifying 
deceptive and illegal labeling and marketing practices of Smart Balance Blended 
Butter Sticks, whose labels claim in big print to “help block cholesterol.” 
CSPI argues that the statement is an illegal disease-prevention claim as well 
as an illegal health claim. By marketing the sticks as preventing or treating 
hypercholesterolemia, CSPI alleges that under the FDCA, the products should 
be considered unapproved new drugs. While there is an FDA-approved health 
claim for some foods that do have plant sterol esters, CSPI claims that Smart 
Balance’s Blended Butter Sticks do not contain enough of those sterols or 
certain beneficial nutrients, and have too much unhealthful saturated fat, 
to qualify. In its letter, CSPI invited Smart Balance to resolve the deceptive 
practices before it seeks legal action. 126 
D. Unauthorized Nutrient Content Claims 
Recent lawsuits have also challenged food manufacturers’ use of nutrient content claims. 
Although the FDA has issued Warning Letters for violation of its nutrient content claim 
regulations, those Letters have had little to no effect on other manufacturers making similar 
claims. For example, on July 15, 2011 the FDA sent a Warning Letter to Natural Guidance, 
LLC informing the company that its claims regarding the benefits of Omega-3s in curing 
“Child depression, Breast, Colon, and Prostate Cancer,” violated the FDCA because these 
disease treating claims can only be made on drugs.127 The FDA also determined that the 
company made several unauthorized Omega-3 and antioxidant claims which did not meet 
the requirements for those type of claim as prescribed in the regulations. For example, the 
claim “30% More Antioxidants than Blueberries” on its Whole Food Bars failed to include the 
names of the nutrients that are the subject of the claim nor did they provide the names of the 
nutrients with recognized antioxidant activity in accordance with FDA’s regulations.
A 2012 lawsuit against Bumble Bee alleged that similarly improper Omega-3 claims were 
made, which makes the products drugs under the FDCA, therefore requiring pre-approval by 
the FDA.128 The plaintiffs also asserted that Bumble Bee made illegal nutrient content claims 
because FDA regulations prohibit claims that the product is a “good source” or “excellent 
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source” of a nutrient unless the nutrient has an established DV. Bumble Bee products labeled 
“Rich in Natural Omega-3” or “Excellent Source of Omega-3” are allegedly misbranded 
because, among other reasons, Omega-3 does not have an established DV. 
The FDA has also sent several Warning Letters to companies regarding the unauthorized use 
of the nutrient content claim “no sugar added.”129 However, these letters have not deterred 
other companies from violating the same regulations. In a lawsuit filed this January 2014, 
plaintiffs alleged that Nestle’s Eskimo Pies products are misbranded because the claim “no 
sugar added” on the products’ labels failed to meet the regulatory requirements. In particular, 
the FDA requires that unless an exception applies, “no sugar added” claims may be made only 
if two additional statements are included on a label: 1) that the product is not a “low calorie” 
or “calorie reduced” and 2) a statement that directs the consumer’s attention to the nutrition 
panel for more information on sugar and calorie content. Plaintiffs asserted that these 
requirements were not met, thereby constituting a violation of federal and state law.130
Although in 2010 the FDA warned Beech-Nut Nutrition Corporation that Beech-Nut that 
claims on its baby and toddler foods were unauthorized nutrient content claims,131 competitor 
Gerber was sued in 2012 for making similar claims.132 The plaintiff alleged that Gerber, which 
reportedly controls between 70 and 80 percent of the baby food market in the United States, 
makes nutrient content claims such as “healthy” on virtually all Gerber food products, despite 
the fact that the FDA does not allow nutrient content claims on foods for children under age 
two. Plaintiffs also alleged that many of Gerber’s products that are labeled with a “No Added 
Sugar” or “No Added Refined Sugar” nutrient content claim contain sufficiently high levels 
of calories that FDA’s regulations requires that the claims be accompanied by a disclosure 
statement warning of the higher caloric level of the products.133 Because Gerber does not place 
a disclosure statement on food products requiring a disclosure statement, the plaintiff asserts 
that Gerber’s product labels violate federal and state laws.134
These recent lawsuits reveal that consumers and food manufacturers require the FDA’s 
guidance regarding unregulated common labeling claims such as “natural,” and the FDA’s 
enforcement of flagrant labeling violations. 
CLOSING THE GAPS IN REGULATORY ENFORCEMENT
The FDA must address, not avoid, key food labeling controversies that have been exposed 
by the food labeling lawsuits. The following is a list of recommendations for FDA regulatory 
reform. 
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1. The FDA should define misleading terms such as “natural” to achieve uniformity and 
consistency for consumers and food manufacturers. 
Consumers’ inherent lack of knowledge about food ingredients, food technology, food 
ingredient terminology, and marketing claims places them at a disadvantage when trying to 
evaluate the “naturalness” of a product or ingredient. Therefore, consumers should be able 
to rely on the FDA to provide food manufacturers with clear regulations about how the term 
“natural” may be used. The FDA’s 1993 policy addressing “added color, artificial flavors or 
synthetic substances” fails to resolve issues regarding HFCS, enriched flour, modified starch, 
partially hydrogenated vegetable oils, organic solvents such as hexane, genetically engineered 
ingredients, and pesticides. As the FDA has recognized, its longstanding policies on “natural” 
claims have been challenged by advances in food processing and in packaging methods. 
As manufacturers continue to develop new ingredients and methods of processing foods, 
determining whether a food is “natural” will become even more complex.135 It is within the 
FDA’s purview to address the question of what constitutes a “natural” ingredient, so that the 
term may be used consistently by manufacturers. 
GM ingredients are at the heart of many of the “natural” class-action labeling suits against 
food manufacturers. Although the FDA does not recognize any meaningful difference between 
GMOs and foods developed traditionally, the lawsuits allege that GMOs are unnatural. The FDA 
should provide more definitive guidance to food producers and it should revisit its non-binding 
2001 draft guidance on voluntary GMO labeling.136 The FDA has stated that it is currently 
reviewing its regulation of GMOs and its position on labeling; however there is no indication 
that the agency is actively undertaking this pressing task.137 
GMO labeling is a controversial issue that demands that FDA’s expertise and attention. 
Otherwise, federal judges or state legislatures will be making determinations about the 
naturalness of GMOs in regards to food labels. In the absence of clear guidance from the FDA, 
the issue of whether food containing GMOs may be labeled “natural” has been addressed 
by several state legislatures in bills requiring the labeling of GMO foods. On April 23, 2014, 
Vermont became the first state to require labeling of all foods containing genetically 
engineered ingredients. Connecticut and Maine have also enacted such laws, but the labeling 
laws in both states are contingent upon several requirements. Labeling laws have also been 
proposed in twenty-six states. For example, GMO labeling bills proposed in Indiana138 and 
Massachusetts139 would prohibit GMO foods from being labeled as “natural.” According to 
Connecticut’s new law, “ ‘natural food’ . . . has not been treated with preservatives, antibiotics, 
synthetic additives, artificial flavoring or artificial coloring”” “has not been processed in a 
manner that makes such food significantly less nutritive;”;and “has not been genetically-
engineered.” 140 A food that is processed “by extracting, purifying, heating, fermenting, 
concentrating, dehydrating, cooling or freezing shall not, of itself, prevent the designation of 
such food as ‘natural food.’ ”141 California’s defeated Genetically Engineered Foods Labeling 
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ballot initiative, Proposition 37,142 also prohibited the labeling of foods containing GMOs as 
“natural,” but its standard went further and could be interpreted as prohibiting the labeling 
or advertising any processed food as “natural.” 143 This definition of “natural” would have 
conflicted with the standard in Connecticut. “Processed food” was defined to mean “any 
food other than a raw agricultural commodity, and includes any food produced from a raw 
agricultural commodity that has been subject to processing such as canning, smoking, 
pressing, cooking, freezing, dehydration, fermentation, or milling.”144 Such a strict standard 
for “natural” would prohibit smoked almonds or frozen vegetables, for example, from being 
labeled as “natural.”
These state attempts to define “natural” exemplify the inconsistencies that will result if the 
FDA leaves this issue to be addressed by courts or legislatures. As the Food Marketing Institute 
recently announced, a national uniform standard for non-GMO food products is required 
to avoid “inconsistent and confusing pitfalls of a state-by-state patchwork of GMO labeling 
system.”145 Despite the costs and challenges, the FDA has the statutory mandate and expertise 
to codify the term’s meaning, identify conditions of its use, and specify labeling requirements 
for “natural” claims.
2. The FDA should address the misleading nature of health and nutrition claims and 
revise its regulations accordingly. Although the research conducted by the FDA and 
other groups proves that consumers are confused about these claims, the FDA has not 
increased its enforcement efforts.
In 2011, the Government Accountability Office (GAO) investigated the FDA’s oversight 
of qualified health claims and structure/function claims. The report concluded that 
consumers find it difficult to understand the differences between qualified health 
claims and health claims with significant scientific agreement. Accordingly, the FTC 
has stated that qualified claims based on evidence that is inconsistent with the 
majority of scientific evidence could potentially mislead consumers and, therefore, 
are likely to violate the FTC Act.146 The American Medical Association has also 
vigorously objected to the use of qualified health claims on foods because research 
demonstrates that qualifying language does not remedy the possible deceptiveness 
of qualified health claims. The FDA should reexamine its position regarding the use of 
qualified health claims in light of considerable evidence of consumer confusion.
Consumers have similar difficulties understanding the differences among health, structure/
function, and other health- and nutrient-related claims.147 For example, a study conducted by 
the AARP revealed that more than a third of the respondents could not distinguish between 
health claims and structure/function claims. When asked to compare “calcium reduces the 
risk of osteoporosis” (which is a health claim) and “calcium builds strong bones” (a structure/
function claim), thirty-eight percent (38%) of respondents thought the claims had the same 
Food Labeling Litigation        22
meaning.148 As discussed above, the FDA pre-approves health claims, but does not authorize 
or pre-approve structure/function claims. Furthermore, the FDA has not indicated the level 
of scientific support needed to prevent false or misleading information for this type of claim. 
Because consumers cannot distinguish between structure/function claims and health claims 
for foods, the FDA should develop clear rules for the use of structure/function claims and 
should also apply the significant scientific agreement standard to these claims. Requiring 
pre-approval of structure/function claims could also help protect consumers from deceptive 
use of these claims.
3. The FDA should increase its monitoring and enforcement of labeling practices. 
Policing labeling violations is the responsibility of the FDA, not plaintiffs’ attorneys. To properly 
fulfill its statutory mission, the FDA will require an increased budget and the political will to 
monitor the marketplace. As the above discussion of labeling litigation has demonstrated, 
the FDA’s Warning Letters have had little to no success in deterring companies from violating 
the FDCA and its regulations. The FDA should increase its enforcement efforts to monitor 
misleading claims. 
Unlike the FTC, which may compel food companies to substantiate claims by providing the 
scientific support for statements made in advertisements,149 the FDA bears the burden of 
proving that a structure/function claim, which does not require FDA’s pre-approval, is false 
or misleading without having the authority to compel companies to produce the evidence 
asserted by companies as support for their labeling claims.150 Unless the FDA obtains 
authorization from Congress to require substantiation for claims, it will be costly and time 
consuming for the FDA to establish whether structure/function claims are supported by 
scientific evidence. However, because the line between labeling and advertising is often blurred 
and the misleading claims may be made on the label, on a company’s website, in print, and on 
television, the FDA could work more closely with the FTC to monitor these claims. As discussed 
above, developing clear rules for the scientific support required for structure/function claims 
would also help food companies understand the requirements for asserting these claims. 
Although the FDA has been given an inspection mandate for the first time under the Food 
Safety Modernization Act, the legislation requires inspections to be based on food safety 
risk. While “high risk” facilities will be inspected once every three years, all other domestic 
food facilities must be inspected at least once every five years. Inspections conducted this 
infrequently will be unlikely to keep the FDA current on labeling practices. The FDA should 
develop a system for monitoring labeling violations of products on supermarket shelves in 
addition to routine company inspections, when food safety issues are primarily at issue. The 
FDA should also conduct consumer research on common claims, such as “wholesome,” “pure,” 
and “simple” to understand consumer expectations and whether the products bearing 
these claims meet these expectations. This research can be used to determine which claims 
are misleading.
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As the GAO recommended in its 2011 report, FDA inspectors must be better trained to review 
food labels.151 Although the Compliance Program Guidance Manual, which provides instructions 
for inspectors, contains the requirements for the nutrition facts panel, identifies allergens 
that must be declared, and identifies the statute and regulations for health and nutrient 
content claims, it does not provide instructions to help inspectors identify potentially false or 
misleading structure/function claims on food. FDA can provide inspectors with more specific 
instructions on how to identify potentially false or misleading claims.
CONCLUSION
Certainly, food manufacturers are responsible for the claims they make on their products. 
However, in the absence of clear FDA guidance on certain issues such as what level of scientific 
support is required for structure/function claims, what constitutes a “natural” product, and 
whether GMOs should be labeled, both consumers and food producers are confused. Clarity 
from the FDA is required for food producers to understand the rules, and enforcement by the 
FDA is necessary to ensure a level playing field in the marketplace.
Ultimately, litigation should be unnecessary if the FDA is funded and properly staffed to fulfill 
its regulatory mission—to protect consumers from misleading claims on food labels. In the 
absence of effective regulatory enforcement action against food and beverage manufacturers 
making misleading claims, consumer protection groups and plaintiffs’ attorneys have stepped 
in to fill a void. However, regulation by litigation is a costly and slow process that is unlikely 
to affect widespread change. Furthermore, ceding authority over food labeling to judges is 
contrary to the Nutrition Labeling and Education Act’s purpose of establishing uniform food 
labeling laws. Failure to enforce regulations and monitor the marketplace for deceptive and 
misleading labeling undermines Congress’ intention to provide consumers with truthful food 
labeling information that enables them to make healthy food choices.
Food Labeling Litigation        24
ENDNOTES
1  U.S. Chamber Institute for Legal Reform, The New Lawsuit Ecosystem, pg. 89 (Oct. 2013), http://www.institutefor-
legalreform.com/uploads/sites/1/The_New_Lawsuit_Ecosystem_pages_web.pdf
2  U.S. Chamber Institute for Legal Reform, The New Lawsuit Ecosystem, pg. 90 (Oct. 2013), http://www.institutefor-
legalreform.com/uploads/sites/1/The_New_Lawsuit_Ecosystem_pages_web.pdf (quoting John A. Vogt & Hannah R. 
Kim, Food Labeling: The Next Wave of Consumer Class Actions, Bloomberg BNA Product Safety & Liability Reporter, 
41 PSLR 565, May 6, 2013).
3  U.S. Chamber Institute for Legal Reform, The New Lawsuit Ecosystem, pg. 88 (Oct. 2013), http://www.institutefor-
legalreform.com/uploads/sites/1/The_New_Lawsuit_Ecosystem_pages_web.pdf 
4  2013 Annual Report on Food Facilities, Food Imports, and FDA Foreign Offices, FDA (Nov. 2013). http://www.fda.
gov/Food/GuidanceRegulation/FSMA/ucm376478.htm.
5  Fellner v. Tri-Union Seafoods, 539 F.3d 237, 251 (3d Cir. 2008) (citing 21 U.S.C. § 341 (2006)).
6  Nutrition Labeling and Education Act (NLEA) of 1990, Pub. L. No. 101-535, 104 Stat. 2353 (codified at 21 U.S.C. § 
343 (1990). 
7  The Impact of the Nutrition Labeling and Education Act of 1990 on the Food Industry, 47 Admin. L. Rev. 605, 606 
(1995).
8  21 U.S.C. § 343(a) (2012).
9  15 U.S.C. §§ 45, 52, 55 (1980).
10 Working Agreement Between FTC and Food and Drug Administration, 4 Trade Reg. Rep. (CCH) ¶ 9,850.01 (1971); 
Enforcement Policy Statement on Food Advertising (May 1994), http://www.ftc.gov/enforcement-policy-statement-
on-food-advertising#5.
11  See FDA, Compliance Program Manual, http://www.fda.gov/Food/ComplianceEnforcement/FoodCompliancePro-
grams/ucm238066.htm
12  21 U.S.C. § 334 (2012).
13  21 U.S.C. § 333(f)(2)(A). 
14 21 U.S.C. § 334(a)(1).
15 21 U.S.C. § 336. 
16 21 C.F.R. § 101.14(a)(1).
17  The requirements for health claim petitions are specified in 21 C.F.R. 101.70, and the general requirements for 
health claims are in 21 C.F.R. 101.14.
18 21 C.F..R. § 101.14(c).
19 21 C.F.R. § 101.14(a)(4).
20 21 C.F.R. § 101.14(e)(6).
21  21 C.F.R. § 101.14(d)(2)(vii).
22  21 C.F.R. 101.13.
23  21 C.F.R. 101.65(d)(2).
Food Labeling Litigation        25
24  21 U.S.C. 343(r)(6); 21 C.F.R. 101.93.
25  Center for Disease Control, http://www.cdc.gov/chronicdisease/resources/publications/aag/obesity.htm.
26  http://www.cdc.gov/obesity/data/adult.html.
27  Technomic’s Healthy Eating Consumer Trend Report, available at http://newhope360.com/new-products/con-
sumers-ideas-healthy-foods-changing
28  USDA, Agricultural Resources and Environmental Indicators, 2012 Edition, Craig Osteen, Jessica Gottlieb, and 
Utpal Vasavada, editors pg 37-38, available at http://www.ers.usda.gov/publications/eib-economic-information-bulle-
tin/eib98.aspx#.UyxdjPldU_Y
29  James Matson, Martha Sullins, and Chris Cook, The Role of Food Hubs in Local Food Marketing , USDA Rural 
Development Service Report, pg. 7 (Jan. 2013).
30  USDA, Agricultural Marketing Service (AMS), National Count of Farmers Market Directory Listing Graph: 1994-
2013 http://www.ams.usda.gov/AMSv1.0/ams.fetchTemplateData.do?template=TemplateS&leftNav=WholesaleandFar
mersMarkets&page=WFMFarmersMarketGrowth&description=Farmers%20Market%20Growth
31  Mike Esterl, The Natural Evolution of Food Labels, Wall St. J., Nov. 6, 2013, at B1.
32  Ronnie Cummins, Organic Retailers and Consumers Demand Truth in Labeling, Organic Consumers Association 
(March 7, 2013), http://www.organicconsumers.org/articles/article_27144.cfm.
33  Steve W. Martinez, Introduction of New Food Products With Voluntary Health- and Nutrition-Related Claims, 
1989-2010, EIB-108, U.S. Department of Agriculture, Economic Research Service, pg. 1, February 2013.
34  Lee JW, Shimizu M, Wansink B. Health halo effect: don’t judge a food by its organic label, available at http://
www.sciencedaily.com/releases/2011/04/110410130831.htm.; John Tierney, Health Halo Can Hide the Calories, N.Y. 
Times (Dec. 8, 2008) available at, http://www.nytimes.com/2008/12/02/science/02tier.html. 
35  Margaret Hamburg, M.D., Comm’r FDA, Remarks at the Atlantic Food Summit, Washington, D.C. (March 4, 2010) 
http://www.fda.gov/newsevents/speeches/ucm209924.htm.
36  CSPI, Rebuttal to FDA Report to Congress on Agency Enforcement Actions Regarding Health-Related Claims on 
Food Labels (July 18, 2006), available at http://cspinet.org/new/pdf/fn5rep.pdf. noting the decline of the FDA’s label-
ing enforcement since 2001.
37  https://www.cspinet.org/litigation/
38  S. Rep. No. 109-92, at 153 (2005).
39  H.R. Rep. No. 109-102, at 83 (2005).
40  GAO, Food Labeling: FDA Needs to Better Leverage Resources, Improve Oversight and Effectively Use Avail-
able Data to Help Consumers Select Healthy Foods, GAO-08-597 (Sept. 2008), available at http://www.gao.gov/new.
items/d08597.pdf.
41 CSPI, Rebuttal to FDA Report to Congress on Agency Enforcement Actions Regarding Health-Related Claims on 
Food Labels, (July 18, 2006), http://cspinet.org/new/pdf/fn5rep.pdf.
42  GAO, Food Labeling: FDA Needs to Better Leverage Resources, Improve Oversight and Effectively Use Available 
Data to Help Consumers Select Healthy Foods, GAO-08-597 (Sept. 2008), pg. 5-6, available at http://www.gao.gov/
new.items/d08597.pdf.
43  GAO, Food Labeling: FDA Needs to Better Leverage Resources, Improve Oversight and Effectively Use Available 
Data to Help Consumers Select Healthy Foods, GAO-08-597, pg. 5. (Sept. 2008).
Food Labeling Litigation        26
44  Guidance for Industry: Letter Regarding Point of Purchase Food Labeling, available at http://www.fda.gov/food/
guidanceregulation/guidancedocumentsregulatoryinformation/labelingnutrition/ucm187208.htm
45  Center for Science in the Public Interest (CSPI), Food Labeling Chaos pt. X-4 (2010), iii, available at http://www.
cspinet.org/new/pdf/food_labeling_chaos_report.pdf.
46  Open Letter to Industry from Dr. Hamburg, (March 3, 2010) http://www.fda.gov/food/ingredientspackagingla-
beling/labelingnutrition/ucm202733.htm
47  Michael Taylor, How the FDA Is Picking Its Food Label Battles, The Atlantic (July 19, 2010), http://www.theatlan-
tic.com/health/archive/2010/07/how-the-fda-is-picking-its-food-label-battles/59927/
48  Stephanie Strom, Lawyers From Suits Against Big Tobacco Target Food Makers, NY Times (Aug. 18, 2012) http://
www.nytimes.com/2012/08/19/business/lawyers-of-big-tobacco-lawsuits-take-aim-at-food-industry.html.
49  Dannon Activia and DanActive Settlement, http://www.bholaw.com/dannon.html.
50  Pappas v. Naked Juice Co. of Glendora, No. 2:11-cv-08276-JAK-PLA (C.D. Cal. Aug. 7, 2013); https://www.naked-
juiceclass.com/
51  Johnson v. General Mills, No. 8:10-cv-00061 (C.D. Cal. 2013)  
52  Dennis v. Kellogg Co., No. 3:09-cv-01786-IEG-WMC (S.D. Cal. Sept. 10, 2013); http://www.cerealsettlement.com/
53  Final Judgment at 1, Trammel v. Barbara’s Bakery, Inc., No. 3:12-cv-02664-CRB (N.D. Cal. Nov. 8, 2013), https://
barbarasbakerysettlement.com/
54  http://www.fda.gov/iceci/enforcementactions/warningletters/ucm162943.htm
55    In In re Cheerios Marketing & Sales Practices Litigation, No. 09-cv-2413, 2012 WL 3952069 (D.N.J. Sept. 10, 
2012) (dismissing the suit and granting General Mills’ motion for summary judgment).
56 Warning Letter from FDA to Alexia Foods, Inc. (Nov. 16, 2011) (Roasted Red Potatoes & Baby Portabella Mush-
rooms claimed to be “All Natural” but they contained “disodium dihydrogen pyrophosphate, which is a synthetic 
chemical preservative”), available at http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2011/ucm281118.
htm. 
57  In Re Alexia Foods Inc. Litigation, Case No. 4:11-cv-06119-PJH (N.D. Cal.).
58  (In Chambers) Order Re Motion For Preliminary Approval of Class Action Settlement at 1, Order Granting Pre-
liminary Approval of Class Action Settlement at 1, In re: Alexia Foods, Inc. Litig., No. 4:11-cv-06119-PJH (N.D. Cal. Jul. 
10, 2013), Alexia Settlement Website, https://alexiasettlement.com/mainpage/Home.aspx.
59  Marquez v. Overseas Food Distributors, No. BC 535015 (Cal. Super., Los Angeles County Jan. 32, 2014).
60  Ebin v. Kangadis Food Inc., No. 1:13-cv-2311 (S.D.N.Y.).
61  Merrell Dow Pharm. Inc. v. Thompson, 478 U.S. 804, 806–07, 810 (1986); Holloway v. Bristol-Myers Corp., 485 F.2d 
986, 997 (D.C. Cir. 1973). See Buckman Co. v. Plaintiffs’ Legal Comm., 531 U.S. 341, 349 n.4 (2001) (“The FDCA leaves 
no doubt that it is the Federal Government rather than private litigants who are authorized to file suit for noncom-
pliance with the [FDCA]”). 
62  21 U.S.C. § 343–1(a).
63  Cal. Health & Safety Code § 110100 et seq. See, e.g., Cal. Health & Safety Code § 110660 (“Any food is misbrand-
ed if its labeling is false or misleading in any particular.”).
64  See, e.g., Class Action Complaint at 1–2, Janney v. Gen. Mills, 944 F. Supp. 2d 806 (N.D. Cal. 2013) (No. 4:12-cv-
03919-PJH) (alleging violations of California’s Unfair Competition Law, False Advertising Law, and unjust enrich-
ment); Class Action Complaint at 2, Briseño v. ConAgra Foods, Inc., No. CV11-05379MMM (AGBx), 2011 WL 7939790 
Food Labeling Litigation        27
(C.D. Cal. June 28, 2011) (alleging breach of express warranty along with claims under California’s false advertising 
law, California’s unfair competition law, and California’s Consumer Legal Remedies Act); Class Action Complaint at 
1–2, 16–17, Lockwood v. ConAgra Foods, Inc., 597 F. Supp. 2d 1028 (N.D. Cal. 2009) (No. 3:08-CV-04151-CRB) (seeking 
injunctive relief and restitution on behalf of a class of California consumers for unlawful and deceptive business acts 
and practices and false advertising).
65  Cal. Bus. & Prof. Code § 17200; see, e.g., Lockwood, 597 F. Supp. 2d at 1029.
66  § 17500; see, e.g., Ries v. Arizona Beverages USA, 287 F.R.D. 523, 527 (N.D. Cal. 2012).
67  Cal. Civ. Code § 1750; see, e.g., Miller v. Ghirardelli Chocolate Co., 912 F. Supp. 2d. 861, 863 (N.D. Cal. 2012).
68  See Cal. Civ. Code § 1770 ; Cal. Bus. & Prof. Code §§ 17200, 17500.
69  Cal. Health & Safety Code § 110670 (“Any food is misbranded if its labeling does not conform with the require-
ments for nutrient content or health claims as set forth in Section 403(r) (21 U.S.C. Sec. 343(r)) of the [FDCA] and 
the regulations adopted pursuant thereto.”)
70  Mike Esterl, The Natural Evolution of Food Labels, Wall St. J., Nov. 6, 2013, at B1.
71  Food Labeling: Nutrient Content Claims; General Principles, Petitions, Definitions of Terms, 56 Fed. Reg. 60,421, 
60,466 (proposed Nov. 27, 1991); Food Labeling: Nutrient Content Claims, General Principles, Petitions, Definition of 
Terms; Definitions of Nutrient Content Claims for the Fat, Fatty Acid, and Cholesterol Content of Food, 58 Fed. Reg. 
2302, 2407 (Jan. 6, 1993) (to be codified at 21 C.F.R. pts. 5, 101).
72  Food Labeling: Nutrient Content Claims, General Principles Petitions, Definition of Terms, 56 Fed. Reg. at 
60,466.
73  21 C.F.R. § 10.85(d), (e), (j) (1996).
74  Food Labeling: Nutrient Content Claims, General Principles, Petitions, Definition of Terms; Definitions of Nutri-
ent Content Claims for the Fat, Fatty Acid, and Cholesterol Content of Food, 58 Fed..Reg. 2,302, 2,397 (Jan. 6, 1993).




79  What is the meaning of ‘natural’ on the label of food?, FDA, http://www.fda.gov/AboutFDA/Transparency/Ba-
sics/ucm214868.htm (last updated Apr. 4, 2012).
80  Cox, 2013 WL 3828800, at *2; see also Elaine Watson, FDA ‘Respectfully Declines’ Judges’ Plea for It to Deter-
mine if GMOs Belong in All-Natural Products, Food navigator-usa.com (Jan. 8, 2014), http://www.foodnavigator-usa.
com/Regulation/FDA-respectfully-declines-judges-plea-for-it-to-determine-if-GMOs-belong-in-all-natural-products. 
81 Id. at *1.
82  Id. at *2 (citing Opposition to Defendant’s Motion to Dismiss First Amended Class Action Complaint at 12, Cox, 
2013 WL 3828800, ECF No. 47).
83  Id.
84  Id. (alteration in original) (quoting Pom Wonderful, LLC v. Coca-Cola Co., 679 F.3d 1170, 1176, 1178 (9th Cir. 2012)).
85  See Letter from Leslie Kux, Assistant Comm’r for Policy, FDA, to Judges Yvonne Gonzalez Rogers, Jeffrey S. 
White, & Kevin McNulty 3 (Jan. 6, 2014), available at www.hpm.com/pdf/blog/FDA%20Lrt%201-2014%20re%20
Food Labeling Litigation        28
Natural.pdf (“[W]e respectfully decline to make a determination at this time regarding whether and under what 
circumstances food products . . . may or may not be labeled ‘natural.’ ”).





91   Id.
92  See, e.g., Warning Letter from FDA to Shemshad Food Prod., Inc. (Mar. 11, 2011) (Lime Juice Natural product 
cited for natural claim because product had sodium benzoate 1% (chemical preservative)), available at http://www.
fda.gov/ICECI/EnforcementActions/WarningLetters/ucm247908.htm; Warning Letter from FDA to Bagels Forever, 
Inc. (July 22, 2011) (Blueberry bagel products deemed misbranded because label used the term “All Natural,” when 
they were manufactured with infused wild dry blueberries that contain potassium sorbate (chemical preservative). 
Label also misleadingly made the claim “No Preservatives.”), available at http://www.fda.gov/ICECI/EnforcementAc-
tions/WarningLetters/ucm265756.htm
93  Warning Letter from FDA to Arza Winery LTD (Apr. 3, 2012), available at http://www.accessdata.fda.gov/cms_ia/
importalert_264.html. 
94  E.g., Bates, et al. v. Kashi Co., et al., No. 3:11-cv-01967 (S.D. Cal. filed Aug. 24, 2011). 
95  Astiana v. Ben & Jerry’s Homemade, Inc., Case No. 10-cv-4387 (N.D. Cal. filed Sept. 29, 2010). 
96  Thurston v. Bear Naked, Inc., Case No. 11-cv-4678 (N.D. Cal. filed Sept. 21, 2011). 
97 Hairston v. South Beach Beverage Co., Case No. 12-cv-1429 (C.D. Cal. filed Feb. 21, 2012). 
98  Garrison v. Whole Food Market Inc., No. 13-05333 (N.D. Cal. Nov. 8, 2013).
99  Holk v. Snapple Beverage Corp., Case No. 07-cv-03018 (D. N.J. filed May 2, 2008). 
100  Weiner v. Snapple Beverage Corp., Case No. 07-cv-08742 (S.D.N.Y. filed Oct. 10, 2007). 
101  Lockwood v. ConAgra Foods, Inc., Case No. 08-cv-04151 (N.D. Cal. filed Sept. 2, 2008). 
102  McKenrick v. General Mills, Case No. C12-3919 (N.D.Cal. filed July 26, 2012). 
103 See Weiner v. Snapple Beverage Corp., Case No. 07-cv-08742 (S.D.N.Y.). 
104 See 57 Fed. Reg. 22984 (May 29, 1992), “Statement of Policy: Foods Derived from New Plant Varieties”; FDA’s 
Guidance for Industry Voluntary Labeling Indicating Whether Foods Have or Have Not Been Developed Using Bioen-
gineering; Draft Guidance (Jan. 2001), available at http://www.fda.gov/ food/guidancecomplianceregulatoryinforma-
tion/guidancedocuments/foodlabelingnutrition/ucm059098.htm.
105 See Briseno, et al. v. ConAgra, No. 2:11-cv-05379. Monsanto, Glossary, available at http://www.monsanto.com/
newsviews/Pages/glossary.aspx#g (emphasis added).
106 Lewis v. General Mills, Inc., Case No. BC472451 (Cal. Super. Ct., Los Angeles County filed Oct. 28, 2011). 
107 Shake v. Frito-Lay N. Am., Inc., Case No. 12-cv-00408 (E.D.N.Y. filed Jan. 27, 2012). 
108 Briseno, et al. v. ConAgra, No. 2:11-cv-05379 (C.D. Cal. filed June 28, 2011). 
Food Labeling Litigation        29
109 Bolerjack v. Pepperidge Farm, Inc., No. 12-2918 (U.S. Dist. Ct., D. Colo. filed Nov. 6, 2012). 
110  Red v. Unilever, Case5:10-cv-00387-JW (S.D. Cal. Oct. 29, 2009).
111 Red v. Kraft, Docket No. 2:10-cv-01028 (C.D. Cal. Feb. 11, 2010).
112  https://nutellaclassactionsettlement.com/
113  Class Action Settlement Agreement, In Re: Nutella Marketing And Sales Practices Litigation No. 3:11-cv-01086-
FLW-DEA (Jan. 10, 2012). 
114 Chacanaca v. The Quaker Oats Company, Docket No. 5:10-cv-00502 (N.D. Cal. Feb 03, 2010); http://www.quaker-
lawsuit.com/
115  Lynch v. Tropicana Prods., Inc., No. 2:11-cv-07382 (DMC)(JAD), 2013 WL 2645050 (D.N.J. June 12, 2013).
116  Stark v. Hain Celestial Group Inc., No. 1:13-cv-07246 (S.D.N.Y. Oct. 15, 2013).
117  http://wlflegalpulse.files.wordpress.com/2014/03/evaporated-cane-juice-cases-2-as-of-1-22-2014.pdf
118  Kane v. Chobani, Inc., No. 12-cv–2425, (N.D.Cal. May 14, 2012)
119  See, e.g., Figy v. Lifeway Foods Inc., No. 13-04828 (N.D. Cal. Oct. 17, 2013).
120  Melvin v. Blue Diamond Growers, No. 8:13-cv-1746 (C.D. Cal. Nov. 5, 2013).
121  Gitson v. Trader Joe’s Company, No. 3:13-cv-1333 (N.D. Cal. March 25, 2013).
122  FDA, Draft Guidance for Industry on Ingredients Declared as Evaporated Cane Juice; Reopening of Com-
ment Period; Request for Comments, Data, and Information (March 5, 2014) https://www.federalregister.gov/
articles/2014/03/05/2014-04802/draft-guidance-for-industry-on-ingredients-declared-as-evaporated-cane-juice-
reopening-of-comment#h-7
123  CSPI, Watchdog Group Sues Coke, Nestlé For Bogus “Enviga” Claims, (February 1, 2007) http://www.cspinet.
org/new/200702011.html.
124  Ackerman v. Coca-Cola, No. 09-00395 (E.D. N.Y. May 20, 2009).
125  Auer et al v. Dean Foods Company et al, Docket No. 2:12-cv-00865 (D. Ariz. Apr 25, 2012).
126  Letter from Stephen Gardner & Erika Knudsen to Steve Hughes, Chief Executive Officer,Smart Balance, Inc. 
(Jan. 15, 2014) http://cspinet.org/images/Smart%20Balance%20REVISED%20Demand%20011514.pdf.
127  Warning Letter from FDA to Natural Guidance, LLC (July 15, 2011) http://www.fda.gov/ICECI/EnforcementAc-
tions/WarningLetters/ucm265526.htm
128  For example, Ogden v. Bumble Bee Foods, No. CV12-01828 (N.D. Cal. April 12, 2012).
129  Warning Letter from FDA to Altura Food, Inc. (Sept. 27, 2012) http://www.fda.gov/iceci/enforcementactions/
warningletters/UCM323085
130  Belli v . Nestle USA, Inc., No. 14-cv-0283 (N.D. Cal. Jan. 17, 2014). 
131  21 C.F.R. § 101.13(b)(3) (“Except for claims regarding [certain] vitamins and minerals . . . no nutrient content 
claims may be made on food intended specifically for use by infants and children less than 2 years of age unless the 
claim is specifically provided for” by particular regulations).
132  Warning Letter from FDA to Beech-Nut Nutrition Corporation (Feb. 22, 2010).
Food Labeling Litigation        30
133  21 C.F.R. § 101.60(c)(2).
134  Bruton v. Gerber Products, Case No.: 12-CV-02412-LH (N.D. Cal. May 11, 2012).
135  Nicole E. Negowetti, A National “Natural” Standard for Food Labeling, 65 Me. L. Rev. 581, 594 (2013).
136  FDA, Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or Have Not Been Developed 
Using Bioengineering; Draft Guidance (Jan. 2001) http://www.fda.gov/food/guidanceregulation/guidancedocuments-
regulatoryinformation/labelingnutrition/ucm059098.htm
137  FDA, FDA’s Role in Regulating Safety of GE Foods (May 14, 2013), http://www.fda.gov/forconsumers/consum-
erupdates/ucm352067.htm
138  H.R. 1196, 118th Gen. Assemb., 1st Reg. Sess. (Ind. 2013) (introduced on January 10, 2013).
139  H.R. 2037, Gen. Ct. (Mass. 2013).
140  An Act Concerning Genetically Engineered Food, No. 13-183, § 1(17), 2013 Conn. Pub. Acts 1, 5 (amending § 21a-
92 of Connecticut’s general statutes).
141 Id.
142  Debra Bowen, Cal. Sec’y of State, Statement of Vote November 6, 2012, General Election 13 (2012), available at 
http://www.sos.ca.gov/elections/sov/2012-general/ sov-complete.pdf.
143  Debra Bowen, Cal. Sec’y of State, California General Election: Official Voter Information Guide 55 (2012), avail-
able at http://vig.cdn.sos.ca.gov/2012/general/pdf/complete-vig-v2.pdf. For the relevant, official text of the defeated 
ballot initiative, see id. at 111–12.
144  Id. at 111. But see An Act Concerning Genetically Engineered Food, No. 13-183, § 1(17), 2013 Conn. Pub. Acts 1, 5 
(allowing the natural label on food that “has not been processed in a manner that makes such food significantly less 
nutritive”).
145  Food Marketing Institute (FMI), Board Policy Regarding Genetically Modified Food and Biotechnology, (Jan. 11, 
2014) http://www.fmi.org/docs/default-source/policy-statements/board-policy-regarding-genetically-modified-food-
and-biotechnology2D4B3841ECC3.pdf?sfvrsn=6
146  United States Government Accountability Office, FDA Needs to Reassess Its Approach to Protecting Consumers 
from False or Misleading Claims GAO-11-102, pg. 18-19, Jan 14, 2011.
147  United States Government Accountability Office, FDA Needs to Reassess Its Approach to Protecting Consumers 
from False or Misleading Claims GAO-11-102, pg. 16, Jan 14, 2011.
148  Sandra B. Eskin, AARP Public Policy Institute, Dietary Supplements and Older Consumers 4 (Dec. 2001), http://
assets.aarp.org/rgcenter/consume/dd66_diet.pdf.
149  http://www.ftc.gov/about-ftc/what-we-do/enforcement-authority
150  United States Government Accountability Office, FDA Needs to Reassess Its Approach to Protecting Consumers 
from False or Misleading Claims GAO-11-102, pg. 25, Jan 14, 2011.
151  United States Government Accountability Office, FDA Needs to Reassess Its Approach to Protecting Consumers 
from False or Misleading Claims GAO-11-102, pg. 29, Jan 14, 2011.
Food Labeling Litigation        31
EMAIL YOUR COMMENTS TO GSCOMMENTS@BROOKINGS.EDU
 This paper is distributed in the expectation that it may elicit useful comments and 
is subject to subsequent revision. The views expressed in this piece are those of 




1775 Massachusetts Ave., NW
Washington, DC 20036
Tel: 202.797.6090
Fax: 202.797.6144
brookings.edu/governance.aspx
Editor
Christine Jacobs
Beth Stone
Production & Layout
Beth Stone
